ADA 2021: Encouraging Trial Data On CGMs, Insulin Pens, Digital Solutions, And More

The American Diabetes Association held its 81st Scientific Sessions from 25-29 June, where a range of presentations covering clinical trials of continuous glucose monitors, insulin-delivery systems and remote monitoring technologies were given.

Diabetes Flat Icon Set - Insulin Pump, Glucometer, Syringe, Injection Pen, Lancets, Blood Glucose Test  COPYRIGHT: Shutterstock: HelgaMariah

Results of a “real-world” study showed Medtronic’s InPen “smart” insulin-delivery device helped diabetic users improve their glycemic control in conjunction with a continuous glucose monitor.

Medtronic presented results of the study at the American Diabetes Association (ADA) online conference.

More from Clinical Trials

More from R&D